Source link : https://www.newshealth.biz/health-news/glp-1s-show-no-link-to-aki-with-anticancer-therapy/
SAN DIEGO – Patients receiving cancer treatment, while having an increased risk for acute kidney injury (AKI) linked to various cancer treatment regimens, show no higher risk in relation to exposure to glucagon-like peptide-1 (GLP-1) receptor agonist drugs, a large retrospective analysis shows. “Contrary to our hypothesis, our data suggest that exposure to GLP-1s is […]
Author : News Health
Publish date : 2024-11-01 13:00:55
Copyright for syndicated content belongs to the linked Source.